Phase 2 CT-SBRT, image-guided precision radiotherapy for localized prostate cancer.

This trial evaluates CT-guided SBRT with intrafraction motion monitoring delivered over five fractions in patients with localized prostate cancer. The study assesses treatment efficacy and side effects while incorporating imaging and biospecimen collection. Sponsored by Jonsson Comprehensive Cancer Center, the design explores technological refinements to reduce genitourinary and gastrointestinal toxicities.